Widowati Esti Wahyu, Ernst Sabrina, Hausmann Ralf, Müller-Newen Gerhard, Becker Walter
Institute of Pharmacology and Toxicology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.
Chemistry Study Program, Faculty of Science and Technology, State Islamic University (UIN) Sunan Kalijaga, Yogyakarta 55281, Indonesia.
Biol Open. 2018 Apr 26;7(4):bio032862. doi: 10.1242/bio.032862.
Haploinsufficiency of is a cause of a neurodevelopmental syndrome termed mental retardation autosomal dominant 7 (MRD7). Several truncation mutations, microdeletions and missense variants have been identified and result in a recognizable phenotypic profile, including microcephaly, intellectual disability, epileptic seizures, autism spectrum disorder and language delay. DYRK1A is an evolutionary conserved protein kinase which achieves full catalytic activity through tyrosine autophosphorylation. We used a heterologous mammalian expression system to explore the functional characteristics of pathogenic missense variants that affect the catalytic domain of DYRK1A. Four of the substitutions eliminated tyrosine autophosphorylation (L245R, F308V, S311F, S346P), indicating that these variants lacked kinase activity. Tyrosine phosphorylation of DYRK1A-L295F in mammalian cells was comparable to wild type, although the mutant showed lower catalytic activity and reduced thermodynamic stability in cellular thermal shift assays. In addition, we observed that one variant (DYRK1A-T588N) with a mutation outside the catalytic domain did not differ from wild-type DYRK1A in tyrosine autophosphorylation, catalytic activity or subcellular localization. These results suggest that the pathogenic missense variants in the catalytic domain of DYRK1A impair enzymatic function by affecting catalytic residues or by compromising the structural integrity of the kinase domain.This article has an associated First Person interview with the first author of the paper.
[基因名称]单倍剂量不足是一种名为常染色体显性智力发育迟缓7型(MRD7)的神经发育综合征的病因。已经鉴定出几种截短突变、微缺失和错义变体,它们导致了一种可识别的表型特征,包括小头畸形、智力残疾、癫痫发作、自闭症谱系障碍和语言发育迟缓。DYRK1A是一种进化保守的蛋白激酶,通过酪氨酸自磷酸化实现完全催化活性。我们使用异源哺乳动物表达系统来探索影响DYRK1A催化结构域的致病性错义变体的功能特征。其中四个替代突变消除了酪氨酸自磷酸化(L245R、F308V、S311F、S346P),表明这些变体缺乏激酶活性。尽管在细胞热迁移分析中该突变体显示出较低的催化活性和降低的热稳定性,但哺乳动物细胞中DYRK1A-L295F的酪氨酸磷酸化与野生型相当。此外,我们观察到一个在催化结构域之外发生突变的变体(DYRK1A-T588N)在酪氨酸自磷酸化、催化活性或亚细胞定位方面与野生型DYRK1A没有差异。这些结果表明,DYRK1A催化结构域中的致病性错义变体通过影响催化残基或损害激酶结构域的结构完整性来损害酶功能。本文对该论文的第一作者进行了相关的第一人称访谈。